Educational Wellness Information Only
This platform provides peer-reviewed research summaries and educational content about peptides for wellness and optimization purposes. Nothing on this site is intended as medical advice, diagnosis, or treatment. We do not claim any peptide can diagnose, treat, cure, or prevent any disease. Always consult a licensed healthcare provider before beginning any wellness protocol.
Statements on this site have not been evaluated by the FDA. Compounded preparations are subject to applicable state and federal regulations. Availability and eligibility vary.
Matrixyl (Palmitoyl Pentapeptide-4) vs Melanotan II
An educational, source-based comparison of Matrixyl (Palmitoyl Pentapeptide-4) and Melanotan II — how each peptide works, what it's researched for, and what to know before going deeper.
Topical matrikine researched for collagen stimulation.
A signal peptide that mimics the procollagen-I fragment, stimulating fibroblasts to produce collagen, elastin, and glycosaminoglycans in topical cosmetic research.
- Dermal collagen synthesis
- Fine lines and skin firmness
- • Well tolerated in topical use.
- • Modest improvements; not equivalent to retinoids.
Melanocortin agonist researched for tanning response and libido.
A non-selective melanocortin receptor agonist that stimulates eumelanin production via MC1R and influences appetite, libido, and erectile function via MC3R/MC4R.
- UV-independent pigmentation
- Erythropoietic protoporphyria (related compound, afamelanotide)
- Sexual function (overlap with PT-141)
- • Not FDA-approved.
- • Risk of new or changing nevi — dermatologic monitoring is essential.
- • Common side effects: nausea, flushing, spontaneous erections, appetite suppression.
Trial-evidence rating
Educational grade reflecting how many peer-reviewed studies and FDA actions we cite for each peptide. Not a clinical recommendation.
Early-stage research; conclusions are tentative.
Early-stage research; conclusions are tentative.
Study-by-study comparison
| Peptide | Study | Source | Year | Summary |
|---|---|---|---|---|
| Matrixyl (Palmitoyl Pentapeptide-4) | Palmitoyl pentapeptide-4 in anti-aging skincare | International Journal of Cosmetic Science | 2005 | Improved wrinkle parameters versus placebo in topical trial. |
| Melanotan II | Melanotan and melanocortin receptor pharmacology | Peptides | 2005 | Reviewed pigmentation and behavioral effects of MT-II in animal and human studies. |
Side-effect & safety grid
- Well tolerated in topical use.
- Modest improvements; not equivalent to retinoids.
- Not FDA-approved.
- Risk of new or changing nevi — dermatologic monitoring is essential.
- Common side effects: nausea, flushing, spontaneous erections, appetite suppression.
Educational summary of considerations reported in research literature — not a complete list of adverse events. Discuss with a licensed clinician before any use.
Matrixyl (Palmitoyl Pentapeptide-4) vs Melanotan II — Key differences
- Class: Matrixyl (Palmitoyl Pentapeptide-4) is classified as Skin · Collagen, while Melanotan II is Pigmentation · Melanocortin.
- Primary research focus: Matrixyl (Palmitoyl Pentapeptide-4) — dermal collagen synthesis; Melanotan II — uv-independent pigmentation.
- Tag: Skin vs Skin · Pigmentation.